|
1.
|
el-Serag HB: Epidemiology of
hepatocellular carcinoma. Clin Liver Dis. 5:87–107. 2001.
View Article : Google Scholar
|
|
2.
|
Stebbing J, Filipovic A and Giamas G:
Claudin-1 as a promoter of EMT in hepatocellular carcinoma.
Oncogene. doi:10.1038. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Wang F, He L, Dai WQ, et al: Salinomycin
inhibits proliferation and induces apoptosis of human
hepatocellular carcinoma cells in vitro and in vivo. PLoS One.
7:e506382012. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Wang Y, Liu YH, Jiang JS and Cui HB: A new
method for purification and identification of hepatocellular
carcinoma stem cell of SMMC-7721. Zhonghua Yi Xue Za Zhi.
92:3434–3437. 2012.(In Chinese).
|
|
5.
|
Keung EZ, Nelson PJ and Conrad C: Concise
review: genetically engineered stem cell therapy targeting
angiogenesis and tumor stroma in gastrointestinal malignancy. Stem
Cells. 31:227–235. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Vu NB, Nguyen TT, Tran LC, et al:
Doxorubicin and 5-fluorouracil resistant hepatic cancer cells
demonstrate stem-like properties. Cytotechnology. 65:491–503.
2012.PubMed/NCBI
|
|
7.
|
Song K, Wu J and Jiang C: Dysregulation of
signaling pathways and putative biomarkers in liver cancer stem
cells (Review). Oncol Rep. 29:3–12. 2013.PubMed/NCBI
|
|
8.
|
Lapidot T, Sirard C, Vormoor J, et al: A
cell initiating human acute myeloid leukaemia after transplantation
into SCID mice. Nature. 367:645–648. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Yin AH, Miraglia S, Zanjani ED, et al:
AC133, a novel marker for human hematopoietic stem and progenitor
cells. Blood. 90:5002–5012. 1997.PubMed/NCBI
|
|
10.
|
Miraglia S, Godfrey W, Yin AH, et al: A
novel five-transmembrane hematopoietic stem cell antigen:
isolation, characterization and molecular cloning. Blood.
90:5013–5021. 1997.PubMed/NCBI
|
|
11.
|
de Antonellis P, Liguori L, Falanga A, et
al: MicroRNA 199b-5p delivery through stable nucleic acid lipid
particles (SNALPs) in tumorigenic cell lines. Naunyn Schmiedebergs
Arch Pharmacol. 386:287–302. 2013.PubMed/NCBI
|
|
12.
|
Ma S: Biology and clinical implications of
CD133(+) liver cancer stem cells. Exp Cell Res. 319:126–132.
2013.
|
|
13.
|
Chen Y, Yu D, Zhang H, et al:
CD133(+)EpCAM(+) phenotype possesses more characteristics of tumor
initiating cells in hepatocellular carcinoma Huh7 cells. Int J Biol
Sci. 8:992–1004. 2012.
|
|
14.
|
Nagano H, Ishii H, Marubashi S, et al:
Novel therapeutic target for cancer stem cells in hepatocellular
carcinoma. J Hepatobiliary Pancreat Sci. 19:600–605. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Pang RW and Poon RT: Cancer stem cell as a
potential therapeutic target in hepatocellular carcinoma. Curr
Cancer Drug Targets. 12:1081–1094. 2012.PubMed/NCBI
|
|
16.
|
Na DC, Lee JE, Yoo JE, Oh BK, Choi GH and
Park YN: Invasion and EMT-associated genes are up-regulated in B
viral hepatocellular carcinoma with high expression of CD133-human
and cell culture study. Exp Mol Pathol. 90:66–73. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Thisse B, Stoetzel C, Gorostiza-Thisse C
and Perrin-Schmitt F: Sequence of the twist gene and nuclear
localization of its protein in endomesodermal cells of early
Drosophila embryos. EMBO J. 7:2175–2183. 1988.PubMed/NCBI
|
|
18.
|
Murre C, McCaw PS, Vaessin H, et al:
Interactions between heterologous helix-loop-helix proteins
generate complexes that bind specifically to a common DNA sequence.
Cell. 58:537–544. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Jan YN and Jan LY: HLH proteins, fly
neurogenesis and vertebrate myogenesis. Cell. 75:827–830. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Kadesch T: Consequences of heteromeric
interactions among helix-loop-helix proteins. Cell Growth Differ.
4:49–55. 1993.PubMed/NCBI
|
|
21.
|
Yang J, Mani SA, Donaher JL, et al: Twist,
a master regulator of morphogenesis, plays an essential role in
tumor metastasis. Cell. 117:927–939. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Kwok WK, Ling MT, Lee TW, et al:
Up-regulation of TWIST in prostate cancer and its implication as a
therapeutic target. Cancer Res. 65:5153–5162. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Fu J, Qin L, He T, et al: The
TWIST/Mi2/NuRD protein complex and its essential role in cancer
metastasis. Cell Res. 21:275–289. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Lee TK, Poon RT, Yuen AP, et al: Twist
overexpression correlates with hepatocellular carcinoma metastasis
through induction of epithelial-mesenchymal transition. Clin Cancer
Res. 12:5369–5376. 2006. View Article : Google Scholar
|
|
25.
|
Devereux TR, Stern MC, Flake GP, et al:
CTNNB1 mutations and beta-catenin protein accumulation in human
hepatocellular carcinomas associated with high exposure to
aflatoxin B1. Mol Carcinog. 31:68–73. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Hsu HC, Jeng YM, Mao TL, Chu JS, Lai PL
and Peng SY: Beta-catenin mutations are associated with a subset of
low-stage hepatocellular carcinoma negative for hepatitis B virus
and with favorable prognosis. Am J Pathol. 157:763–770. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Wong CM, Fan ST and Ng IO: beta-catenin
mutation and over-expression in hepatocellular carcinoma:
clinicopathologic and prognostic significance. Cancer. 92:136–145.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Zhang T, Chen X, Qu L, Wu J, Cui R and
Zhao Y: Chrysin and its phosphate ester inhibit cell proliferation
and induce apoptosis in HeLa cells. Bioorg Med Chem. 12:6097–6105.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Woo KJ, Jeong YJ, Park JW and Kwon TK:
Chrysin-induced apoptosis is mediated through caspase activation
and Akt inactivation in U937 leukemia cells. Biochem Biophys Res
Commun. 325:1215–1222. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Lee SJ, Yoon JH and Song KS: Chrysin
inhibited stem cell factor (SCF)/c-Kit complex-induced cell
proliferation in human myeloid leukemia cells. Biochem Pharmacol.
74:215–225. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Ramos AM and Aller P: Quercetin decreases
intracellular GSH content and potentiates the apoptotic action of
the antileukemic drug arsenic trioxide in human leukemia cell
lines. Biochem Pharmacol. 75:1912–1923. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Wang W, VanAlstyne PC, Irons KA, Chen S,
Stewart JW and Birt DF: Individual and interactive effects of
apigenin analogs on G2/M cell-cycle arrest in human colon carcinoma
cell lines. Nutr Cancer. 48:106–114. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Zhang Q, Zhao XH and Wang ZJ: Flavones and
flavonols exert cytotoxic effects on a human oesophageal
adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing
apoptosis. Food Chem Toxicol. 46:2042–2053. 2008. View Article : Google Scholar
|
|
34.
|
Kachadourian R, Leitner HM and Day BJ:
Selected flavonoids potentiate the toxicity of cisplatin in human
lung adenocarcinoma cells: a role for glutathione depletion. Int J
Oncol. 31:161–168. 2007.PubMed/NCBI
|
|
35.
|
Walle T, Otake Y, Brubaker JA, Walle UK
and Halushka PV: Disposition and metabolism of the flavonoid
chrysin in normal volunteers. Br J Clin Pharmacol. 51:143–146.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Park H, Dao TT and Kim HP: Synthesis and
inhibition of PGE2 production of 6,8-disubstituted chrysin
derivatives. Eur J Med Chem. 40:943–948. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Zheng X, Meng WD, Xu YY, Cao JG and Qing
FL: Synthesis and anticancer effect of chrysin derivatives. Bioorg
Med Chem Lett. 13:881–884. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Ai XH, Zheng X, Tang XQ, et al: Induction
of apoptosis of human gastric carcinoma SGC-7901 cell line by 5,
7-dihydroxy-8-nitrochrysin in vitro. World J Gastroenterol.
13:3824–3828. 2007.PubMed/NCBI
|
|
39.
|
Yang XH, Zheng X, Cao JG, Xiang HL, Liu F
and Lv Y: 8-Bromo-7-methoxychrysin-induced apoptosis of
hepatocellular carcinoma cells involves ROS and JNK. World J
Gastroenterol. 16:3385–3393. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Feng X, Zhou Q, Liu C and Tao ML: Drug
screening study using glioma stem-like cells. Mol Med Rep.
6:1117–1120. 2012.PubMed/NCBI
|
|
41.
|
Li Q, Gu X, Weng H, et al: Bone
morphogenetic protein-9 (BMP-9) induces epithelial to mesenchymal
transition (EMT) in hepatocellular carcinoma cells. Cancer Sci.
104:398–408. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Liu FY, Deng YL, Li Y, et al:
Down-regulated KLF17 expression is associated with tumor invasion
and poor prognosis in hepatocellular carcinoma. Med Oncol.
30:4252013. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Tanaka S, Shiraha H, Nakanishi Y, et al:
Runt-related transcription factor 3 reverses epithelial-mesenchymal
transition in hepatocellular carcinoma. Int J Cancer.
131:2537–2546. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
El-Haibi CP, Bell GW, Zhang J, et al:
Critical role for lysyl oxidase in mesenchymal stem cell-driven
breast cancer malignancy. Proc Natl Acad Sci USA. 109:17460–17465.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Singh N, Liu G and Chakrabarty S:
Isolation and characterization of calcium sensing receptor null
cells: a highly malignant and drug resistant phenotype of colon
cancer. Int J Cancer. 132:1996–2005. 2013. View Article : Google Scholar
|
|
46.
|
Yang MH, Chen CL, Chau GY, et al:
Comprehensive analysis of the independent effect of twist and snail
in promoting metastasis of hepatocellular carcinoma. Hepatology.
50:1464–1474. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Barr MP, Gray SG, Hoffmann AC, et al:
Generation and characterisation of cisplatin-resistant non-small
cell lung cancer cell lines displaying a stem-like signature. PLoS
One. 8:e541932013. View Article : Google Scholar : PubMed/NCBI
|
|
48.
|
Meng F, Glaser SS, Francis H, et al:
Functional analysis of microRNAs in human hepatocellular cancer
stem cells. J Cell Mol Med. 16:160–173. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49.
|
Ji J and Wang XW: Clinical implications of
cancer stem cell biology in hepatocellular carcinoma. Semin Oncol.
39:461–472. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Pardal R, Clarke MF and Morrison SJ:
Applying the principles of stem-cell biology to cancer. Nat Rev
Cancer. 3:895–902. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
51.
|
Marx J: Cancer research. Mutant stem cells
may seed cancer. Science. 301:1308–1310. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
52.
|
Swindall AF, Londono-Joshi AI, Schultz MJ,
Fineberg N, Buchsbaum DJ and Bellis SL: ST6Gal-I protein expression
is upregulated in human epithelial tumors and correlates with stem
cell markers in normal tissues and colon cancer cell lines. Cancer
Res. 73:2368–2378. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53.
|
Lehnus KS, Donovan LK, Huang X, et al:
CD133 glycosylation is enhanced by hypoxia in cultured glioma stem
cells. Int J Oncol. 42:1011–1017. 2013.PubMed/NCBI
|
|
54.
|
Zeng Z, Ren J, O’Neil M, et al: Impact of
stem cell marker expression on recurrence of TACE-treated
hepatocellular carcinoma post liver transplantation. BMC Cancer.
12:5842012. View Article : Google Scholar : PubMed/NCBI
|
|
55.
|
Hori Y: Prominin-1 (CD133) reveals new
faces of pancreatic progenitor cells and cancer stem cells: current
knowledge and therapeutic rerspectives. Adv Exp Med Biol.
777:185–196. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
56.
|
Lee HH, Seo KJ, An CH, Kim JS and Jeon HM:
CD133 expression is correlated with chemoresistance and early
recurrence of gastric cancer. J Surg Oncol. 106:999–1004. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
57.
|
Yi H, Cho HJ, Cho SM, et al: Blockade of
interleukin-6 receptor suppresses the proliferation of H460 lung
cancer stem cells. Int J Oncol. 41:310–316. 2012.PubMed/NCBI
|
|
58.
|
Grosse-Gehling P, Fargeas CA, Dittfeld C,
et al: CD133 as a biomarker for putative cancer stem cells in solid
tumours: limitations, problems and challenges. J Pathol.
229:355–378. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
59.
|
Yin S, Li J, Hu C, et al: CD133 positive
hepatocellular carcinoma cells possess high capacity for
tumorigenicity. Int J Cancer. 120:1444–1450. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
60.
|
De Hert M, Dockx L, Bernagie C, et al:
Prevalence and severity of antipsychotic related constipation in
patients with schizophrenia: a retrospective descriptive study. BMC
Gastroenterol. 11:172011.PubMed/NCBI
|
|
61.
|
Qu F, Zhai W, Chen H, Zhu LH and Morris
TJ: Cloning, characterization and transient expression of the gene
encoding a rice U3 small nuclear RNA. Gene. 172:217–220. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
62.
|
Wu Y, Ginther C, Kim J, et al: Expression
of Wnt3 activates Wnt/β-catenin pathway and promotes EMT-like
phenotype in trastuzumab-resistant HER2-overexpressing breast
cancer cells. Mol Cancer Res. 10:1597–1606. 2012.
|
|
63.
|
Grosse-Steffen T, Giese T, Giese N, et al:
Epithelial-to-mesenchymal transition in pancreatic ductal
adenocarcinoma and pancreatic tumor cell lines: the role of
neutrophils and neutrophil-derived elastase. Clin Dev Immunol.
2012:720–768. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
64.
|
Li J and Zhou BP: Activation of
beta-catenin and Akt pathways by Twist are critical for the
maintenance of EMT associated cancer stem cell-like characters. BMC
Cancer. 11:492011. View Article : Google Scholar : PubMed/NCBI
|
|
65.
|
Xiang HL, Zheng X and Cao JG: Induction of
apoptosis of human gastric carcinoma SGC-790 cell line by
8-bromo-7-mehoxychrysin. Zhongguo Yaolixue Tongbao. 24:1370–1372.
2008.
|
|
66.
|
Zhao XC, Tian L, Cao JG and Liu F:
Induction of apoptosis by 5,7-dihydroxy-8-nitrochrysin in breast
cancer cells: the role of reactive oxygen species and Akt. Int J
Oncol. 37:1345–1352. 2010.PubMed/NCBI
|
